LoPriore Vincent S

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 3 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

3
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Hepion Pharmaceuticals, Inc.Executive ChairmanAwardnothing paid1,345,500 sharesAug 21, 2026Hepion Pharmaceuticals, Inc.Executive Chairmannothing paidAward · Aug 21Award1,345,500Aug 21, 2026
Hepion Pharmaceuticals, Inc.Executive ChairmanOpen-market buy$100,0002,000,000 sharesAug 12, 2026Hepion Pharmaceuticals, Inc.Executive Chairman$100,000Buy · Aug 12Open-market buy2,000,000Aug 12, 2026
Hepion Pharmaceuticals, Inc.Executive ChairmanOpen-market buy$400,0008,000,000 sharesAug 12, 2026Hepion Pharmaceuticals, Inc.Executive Chairman$400,000Buy · Aug 12Open-market buy8,000,000Aug 12, 2026